Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Participant Adherence and Glucose Control While Using a Connected Insulin Management Platform

NCT05893797 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.

NCT NCT05893797
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05893797 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Participant Adherence and Glucose Control While Using a Connected Insulin Management Platform
Lead sponsor
Eli Lilly and Company
Phase
Not applicable
Overall status
Completed
Start date
October 5, 2023
Completion date
September 16, 2024
Enrollment
36 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

type 1 diabetes, type 2 diabetes, type 2 diabetes treated with insulin